Please check out the new WECF website on wecf.org!

Stay here to browse our website archive (2004-2018).

WECF Deutschland

WECF France

WECF Nederland

Facebook

Twitter

YouTube

Pregnancy and early life are critical stages for environmental chemical exposure

Evidence to indicate that early exposure to environmental contaminants may result in a greater risk of serious disease later on in life has been presented by researchers in a new White Paper published by the European Commission

05.10.2012 |Science for Environment Policy




Measures to prevent non-contagious illnesses, such as diabetes, asthma and cancer should therefore focus on the early stages in life, including the time spent in the womb, they suggest.

All complex diseases are influenced in some way by the environment. Scientists now have a better understanding of the role of these environmental influences on disease, and while the influence of fixed genetic factors is also important, it is not as significant as previously believed.

The White Paper1 summarises research on the impacts of contaminants in our environment on human biological development, and proposes general recommendations for policy and research. Environmental chemical exposure has been implicated in various non-communicable diseases and major public health problems, such as obesity, diabetes, hypertension, cardiovascular disease, asthma and allergy, infertility, some cancer types, osteoporosis and neurocognitive development. A particularly vulnerable life stage is development in the womb and just after birth, as the foetus or baby are exposed to environmental chemicals via the mother.

Often, the impacts of chemical exposure are not immediately noticeable and some environmental contaminants, especially endocrine disrupting chemicals (EDCs), can result in epigenetic changes that are not observable at birth, but lead to increased risk of dysfunction and disease later in life. For some tissues and organs, such as the brain, reproductive and immune system, developmental vulnerability to adverse effects from environmental chemicals continues through the neonatal period and perhaps into puberty.

EDCs are of particular concern as these disrupt the hormones that carry signals in the body. EDCs can have effects at very low doses and 900 chemicals are now suspected to be EDCs. Examples of EDCs known to affect disease susceptibility as a result of developmental exposures in animal models include some organophosphate and organochlorine pesticides, bisphenol A (from polycarbonate plastics), phthalates (a softener in plastics), nicotine (from tobacco smoking), and polybrominated diphenyl ethers (flame retardants). Often chemicals can have cumulative or interactive effects, when experienced at the same time or at different stages of life. These effects can also interact with nutritional deficiencies and imbalances. The authors pointed to several similarities between the effects of nutritional imbalances and exposure to environmental chemicals.

Because exposure to environmental contaminants tends to have a developmental impact which is often not physically observable until later in life, the researchers stress the importance of identifying and studying effective ‘biomarkers’ that can be measured at birth. Biomarkers are biological characteristics that can be measured to indicate the state of health, for example, anogenitial distance as a biomarker of feminization. In the future it is hoped that epigenetic marks could serve as relevant biomarkers.

The researchers strongly recommend that public policy focuses on disease prevention in key developmental stages and reducing environmental chemical exposure pre-pregnancy, during pregnancy and during the first few years of life.
The current data are sufficiently robust and replicable to require a policy and public health response they suggest, but further research is needed to identify the exposure pathways, i.e. exactly how specific contaminants reach and interact with humans, through the use of biomarkers, and to establish a convincing link between epigenetic alterations and later disease.

1.    The paper was an outcome of the PPTOX III conference on Environmental Stressors in the Developmental Origins of Disease: Evidence and Mechanisms, attended by leading researchers on early exposure to environmental contaminants and diseases.
Source: Barouki, R., Gluckman, P.D., Grandjean, P., Hanson, M. & Heindel, J.J. (2012) Developmental origins of non-communicable disease: Implications for research and public health. Environmental Health. 11(42): 1-9. This study is free to view at: www.ehjournal.net/content/11/1/42 DOI.org/10.1080/13549839.2011.646971.
Contact: Robert.barouki@parisdescartes.fr

Theme(s): Chemicals, Environment and health

The White Paper can be found here as a PDF

Related News

Meet the Winners of the Gender Just Climate Solutions Award at COP24
On the 70th anniversary of the Universal Declaration of Human Rights, we awarded Gender Just Climate Solutions Winners at the climate negotiations in Katowice, Poland
11.12.2018

Invitation: Gender Just Climate Solutions Award 2018
10 December, COP24 Katowice
04.12.2018

Getting to the Future We Want
4-7 November, Brussels: European Environmental Bureau’s (EEB) Annual Conference
12.11.2018

GoodFood4All
WECF and partners all over Europe start GoodFood4All Campaign
06.11.2018